Recruiting NA Endometriosis-related Pain

New treatment option for Endometriosis-related Pain

Official title Transcutaneous Electrical Nerve Stimulation for Endometriosis-related Chronic Pain

ClinicalTrials.gov ID: NCT05152264

What this study is testing

What it's testing
The study evaluates the effect of TENS (transcutaneous electrical nerve stimulation) as add-on treatment compared with conventional analgesic treatment in patients with endometriosis-related chronic pain. Patients with frequent pain and high pain intensity will be randomized to additional treatment with TENS or conventional treatment for 8 weeks to evaluate the acute effects of TENS treatment (n=40).
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 100, women only

You may be able to join if

  • Age ≥18 years
  • Consents to participation in the study
  • Verified endometriosis (by laparoscopy or ultrasound).
  • Chronic endometriosis-related pain (\> 3 months), available for TENS treatment
  • Functioning, stable endometriosis-specific hormonal drug therapy. The endometriosis-specific drug therapy must be unchanged for the last 3 months and...

You likely can't join if

  • Patient with inability to understand and use written and spoken Swedish
  • Patient with pacemaker and/or ICD or other electronic implants
  • Patient with impaired sensation over the painful area
  • Malignant disease with an expected survival \<12 months
  • Alcohol or substance abuse
  • Serious untreated psychiatric illness and/or psychological condition that is the primary determinant of the patient's condition
See the full eligibility criteria
Who can join
  • Age ≥18 years
  • Consents to participation in the study
  • Verified endometriosis (by laparoscopy or ultrasound).
  • Chronic endometriosis-related pain (\> 3 months), available for TENS treatment
  • Functioning, stable endometriosis-specific hormonal drug therapy. The endometriosis-specific drug therapy must be unchanged for the last 3 months and no gynecological surgical procedures for the treatment of...
What rules you out
  • Patient with inability to understand and use written and spoken Swedish
  • Patient with pacemaker and/or ICD or other electronic implants
  • Patient with impaired sensation over the painful area
  • Malignant disease with an expected survival \<12 months
  • Alcohol or substance abuse
  • Serious untreated psychiatric illness and/or psychological condition that is the primary determinant of the patient's condition
  • Participating in another intervention study with possible impact on current study outcome measures
  • Patient who is using \>90 morphine equivalents/day
  • Patient who is electro-acupuncture
  • Pregnancy

The study team makes the final eligibility decision.

Where it's taking place

  • Gothenburg, Sweden

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years to 100 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Gothenburg, Sweden. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.